Shares in biotech group Xilio Therapeutics (XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie Inc. (ABBV). Xilio Targeting Range of Cancers The two companies announced ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ocugen (OCGN – Research Report) and Xilio Therapeutics (XLO – Research Report) with bullish ...

On Wednesday, AbbVie Inc (NYSE:ABBV) and Xilio Therapeutics, Inc. (NASDAQ:XLO) announced a collaboration and option-to-license agreement to develop novel tumor-activated, antibody-based ...

Price Action: XLO stock is up 116.10% at $1.42 at the last check on Wednesday.

WALTHAM, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Short interest in Xilio Therapeutics Inc (NASDAQ:XLO) decreased during the last reporting period, falling from 384.09K to 213.07K. This put 0.56% of the company's publicly available shares short.

$XLO insiders have traded $XLO stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

The family of a British couple in custody in Iran say they are united in their determination to secure their safe return. Craig and Lindsay Foreman were arrested in January, but news of their ...